Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Alpha-1 Antitrypsin Deficiency Today: New Insights in the Immunological Pathways.

Baraldo S, Balestro E, Bazzan E, Tiné ME, Biondini D, Turato G, Cosio MG, Saetta M.

Respiration. 2016;91(5):380-5. doi: 10.1159/000445692. Epub 2016 May 12. Review.

PMID:
27164860
2.

Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.

Cosio MG, Bazzan E, Rigobello C, Tinè M, Turato G, Baraldo S, Saetta M.

Ann Am Thorac Soc. 2016 Aug;13 Suppl 4:S305-10. doi: 10.1513/AnnalsATS.201510-671KV. Review.

PMID:
27564665
3.

Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.

Baraldo S, Turato G, Lunardi F, Bazzan E, Schiavon M, Ferrarotti I, Molena B, Cazzuffi R, Damin M, Balestro E, Luisetti M, Rea F, Calabrese F, Cosio MG, Saetta M.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):402-9. doi: 10.1164/rccm.201403-0529OC.

PMID:
25412116
4.

The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.

McCarthy C, Reeves EP, McElvaney NG.

Ann Am Thorac Soc. 2016 Aug;13 Suppl 4:S297-304. doi: 10.1513/AnnalsATS.201509-634KV. Review.

PMID:
27564664
5.
6.

Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.

Abboud RT, Vimalanathan S.

Int J Tuberc Lung Dis. 2008 Apr;12(4):361-7. Review.

PMID:
18371259
7.

Alpha 1 anti-trypsin: one protein, many functions.

Hunt JM, Tuder R.

Curr Mol Med. 2012 Aug;12(7):827-35. Review.

PMID:
22697349
8.

The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.

Franciosi AN, McCarthy C, McElvaney NG.

Expert Rev Respir Med. 2015 Apr;9(2):143-51. doi: 10.1586/17476348.2015.1002472. Epub 2015 Jan 19. Review.

PMID:
25598013
9.

The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.

O'Dwyer CA, O'Brien ME, Wormald MR, White MM, Banville N, Hurley K, McCarthy C, McElvaney NG, Reeves EP.

J Immunol. 2015 Oct 15;195(8):3628-41. doi: 10.4049/jimmunol.1500038. Epub 2015 Sep 14.

10.

Alpha-1-antitrypsin and other proteinase inhibitors.

Miravitlles M.

Curr Opin Pharmacol. 2012 Jun;12(3):309-14. doi: 10.1016/j.coph.2012.02.004. Epub 2012 Feb 23. Review.

PMID:
22365503
11.

Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?

Abboud RT, Ford GT, Chapman KR.

Treat Respir Med. 2005;4(1):1-8. Review.

PMID:
15725045
12.

The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.

Greene CM, Hassan T, Molloy K, McElvaney NG.

Expert Rev Respir Med. 2011 Jun;5(3):395-411. doi: 10.1586/ers.11.20. Review.

PMID:
21702661
13.

The discovery of α1-antitrypsin and its role in health and disease.

Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T.

Respir Med. 2011 Aug;105(8):1129-39. doi: 10.1016/j.rmed.2011.02.002. Epub 2011 Mar 1. Review.

14.

Pathophysiology of Alpha-1 Antitrypsin Lung Disease.

Kalfopoulos M, Wetmore K, ElMallah MK.

Methods Mol Biol. 2017;1639:9-19. doi: 10.1007/978-1-4939-7163-3_2. Review.

PMID:
28752442
15.

Alpha-1 antitrypsin: now available, but do we need it?

Russi EW.

Swiss Med Wkly. 2008 Apr 5;138(13-14):191-6. doi: 2008/13/smw-11991. Review.

PMID:
18389391
16.

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

Gadek JE, Fells GA, Zimmerman RL, Rennard SI, Crystal RG.

J Clin Invest. 1981 Oct;68(4):889-98.

17.

Augmentation therapy with alpha1-antitrypsin: novel perspectives.

Sabina J, Tobias W.

Cardiovasc Hematol Disord Drug Targets. 2013 Aug;13(2):90-8. Review.

PMID:
23987997
18.

Alpha1-antitrypsin deficiency: forgotten etiology.

Kaplan A, Cosentino L.

Can Fam Physician. 2010 Jan;56(1):19-24. Review.

19.

Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.

Casas F, Blanco I, Martínez MT, Bustamante A, Miravitlles M, Cadenas S, Hernández JM, Lázaro L, Rodríguez E, Rodríguez-Frías F, Torres M, Lara B.

Arch Bronconeumol. 2015 Apr;51(4):185-92. doi: 10.1016/j.arbres.2014.05.008. Epub 2014 Jul 12. English, Spanish.

20.

Endogenous modifiers of cigarette smoke exposure within the lung.

Houghton AM.

Proc Am Thorac Soc. 2012 May;9(2):66-8. doi: 10.1513/pats.201108-046MS.

Supplemental Content

Support Center